1. Whistler D De morbo puerli anglorum, quem patrio ideiomate indigenae vocant "the rickets". Journal of History of Medicine 1645; 5:397-415
2. Mellanby E An experimental investigation on rickets. Lancet 1919; 1:407-412
3. McCollum EV, Simmonds N, Becker JE, Shipley PG An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922; 53:293-298
4. Steenbock H, Black A Fat-soluble vitamins. XVII. The induction of growth-promoting and calcifying properties in a ration by exposure to ultraviolet light. J Biol Chem 1924; 61:405-422
5. Huldshinsky K Heilung von rachitis durch kunstalich hohensonne. Deut Med Wochenschr 1919; 45:712-713
6. Hess AF, Unger LF Cure of infantile rickets by sunlight. Journal of The American Medical Association 1921; 77:39
7. Askew FA, Bourdillon RB, Bruce HM, Jenkins RGC, Webster TA The distillation of vitamin D. Proceedings of the Royal Society 1931; B107:76-90
8. Windaus A, Schenck F, von Werder F Uber das antirachitisch wirksame bestrahlungs-produkt aus 7-dehydro-cholesterin. Hoppe-Seylers Z Physiological Chemistry 1936; 241:100-103
9. Holick MF, McLaughlin JA, Clark MB, Doppelt SH Factors that influence the cutaneous photosynthesis of previtamin D3. Science 1981; 211:590-593
10. Holick MF, McLaughlin JA, Clark MB, Holick SA, J.T. PJ, Anderson RR, Blank IH, Parrish JA Photosynthesis of previtamin D3 in human and the physiologic consequences. Science 1980; 210:203-205
11. Holick MF, Richtand NM, McNeill SC, Holick SA, Frommer JE, Henley JW, Potts JT, Jr. Isolation and identification of previtamin D3 from the skin of rats exposed to ultraviolet irradiation. Biochemistry 1979; 18:1003-1008
12. Webb AR, DeCosta BR, Holick MF Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 1989; 68:882-887
13. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985; 76:470-473
14. Webb AR, Kline L, Holick MF Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67:373-378
15. Matsuoka LY, Wortsman J, Dannenberg MJ, Hollis BW, Lu Z, Holick MF Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab 1992; 75:1099-1103.
16. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987; 64:1165-1168
17. Andersson S, Davis DL, Dahlbäck H, Jörnvall H, Russell DW Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 1989; 264:8222-8229
18. Usui E, Noshiro M, Okuda K Molecular cloning of cDNA for vitamin D3 25-hydroxylase from rat liver mitochondria. FEBS Lett 1990; 262:135-138
19. Cali JJ, Russell DW Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem 1991; 266:7774-7778
20. Ichikawa F, Sato K, Nanjo M, Nishii Y, Shinki T, Takahashi N, Suda T Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1 alpha-hydroxyvitamin D3 into 1 alpha,25-dihydroxyvitamin D3. Bone 1995; 16:129-135.
21. Cali JJ, Hsieh CL, Francke U, Russell DW Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 1991; 266:7779-7783
22. Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz SP, Dann EJ, Berkman N, Cali JJ, Klapholz L, Berginer VM Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J Clin Invest 1993; 91:2488-2496
23. Berginer VM, Shany S, Alkalay D, Berginer J, Dekel S, Salen G, Tint GS, Gazit D Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis [see comments]. Metabolism 1993; 42:69-74
24. Leitersdorf E, Safadi R, Meiner V, Reshef A, Björkhem I, Friedlander Y, Morkos S, Berginer VM Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. Am J Hum Genet 1994; 55:907-915
25. Guo YD, Strugnell S, Jones G Identification of a human liver mitochondrial cytochrome P-450 cDNA corresponding to the vitamin D3-25-hydroxylase. Journal of Bone and Mineral Research 1991; 6:S120
26. Guo YD, Strugnell S, Back DW, Jones G Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc Natl Acad Sci U S A 1993; 90:8668-8672.
27. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem 2003; 278:38084-38093
28. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 2004; 101:7711-7715
29. Theodoropoulos C, Demers C, Mirshahi A, Gascon-Barre M 1,25-Dihydroxyvitamin D(3) downregulates the rat intestinal vitamin D(3)-25-hydroxylase CYP27A. Am J Physiol Endocrinol Metab 2001; 281:E315-325.
30. Axen E, Postlind H, Wikvall K Effects on CYP27 mRNA expression in rat kidney and liver by 1 alpha, 25- dihydroxyvitamin D3, a suppressor of renal 25-hydroxyvitamin D3 1 alpha- hydroxylase activity. Biochem Biophys Res Commun 1995; 215:136-141.
31. Vlahcevic ZR, Jairath SK, Heuman DM, Stravitz RT, Hylemon PB, Avadhani NG, Pandak WM Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am J Physiol 1996; 270:G646-652.
32. Twisk J, Hoekman MF, Lehmann EM, Meijer P, Mager WH, Princen HM Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27- hydroxylase gene transcription. Hepatology 1995; 21:501-510.
33. Stravitz RT, Vlahcevic ZR, Russell TL, Heizer ML, Avadhani NG, Hylemon PB Regulation of sterol 27-hydroxylase and an alternative pathway of bile acid biosynthesis in primary cultures of rat hepatocytes. J Steroid Biochem Mol Biol 1996; 57:337-347.
34. Saarem K, Pedersen JI Sex differences in the hydroxylation of cholecalciferol and of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol in rat liver. Biochem J 1987; 247:73-78
35. Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, Portale AA Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997; 11:1961-1970.
36. Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 1997; 277:1827-1830.
37. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997; 12:1552-1559.
38. Shinki T, Shimada H, Wakino S, Anazawa H, Hayashi M, Saruta T, DeLuca HF, Suda T Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA. Proc Natl Acad Sci U S A 1997; 94:12920-12925.
39. Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998; 338:653-661.
40. Wang JT, Lin CJ, Burridge SM, Fu GK, Labuda M, Portale AA, Miller WL Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet 1998; 63:1694-1702.
41. Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)- hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D- deficiency rickets. Endocrinology 2001; 142:3135-3141.
42. Bikle DD, Nemanic MK, Whitney JO, Elias PW Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry 1986; 25:1545-1548.
43. Murayama A, Takeyama K, Kitanaka S, Kodera Y, Kawaguchi Y, Hosoya T, Kato S Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology 1999; 140:2224-2231.
44. Panda DK, Al Kawas S, Seldin MF, Hendy GN, Goltzman D 25-hydroxyvitamin D 1alpha-hydroxylase: structure of the mouse gene, chromosomal assignment, and developmental expression. J Bone Miner Res 2001; 16:46-56.
45. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86:888-894.
46. Bikle D Extra renal synthesis of 1,25 dihydroxyvitamin D and its Health Implications. Clin Rev in Bone and Min Metab 2009; 7:114-125
47. Bikle DD, Pillai S Vitamin D, calcium, and epidermal differentiation. Endocrine Review 1993; 14:3-19
48. Horiuchi N, Suda T, Takahashi H, Shimazawa E, Ogata E In vivo evidence for the intermediary role of 3',5'-cyclic AMP in parathyroid hormone-induced stimulation of 1alpha,25-dihydroxyvitamin D3 synthesis in rats. Endocrinology 1977; 101:969-974.
49. Rasmussen H, Wong M, Bikle D, Goodman DB Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest 1972; 51:2502-2504.
50. Rost CR, Bikle DD, Kaplan RA In vitro stimulation of 25-hydroxycholecalciferol 1 alpha-hydroxylation by parathyroid hormone in chick kidney slices: evidence for a role for adenosine 3',5'-monophosphate. Endocrinology 1981; 108:1002-1006.
51. Henry HL Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin. Endocrinology 1985; 116:503-510.
52. Armbrecht HJ, Forte LR, Wongsurawat N, Zenser TV, Davis BB Forskolin increases 1,25-dihydroxyvitamin D3 production by rat renal slices in vitro. Endocrinology 1984; 114:644-649.
53. Janulis M, Tembe V, Favus MJ Role of protein kinase C in parathyroid hormone stimulation of renal 1,25-dihydroxyvitamin D3 secretion. J Clin Invest 1992; 90:2278-2283.
54. Janulis M, Wong MS, Favus MJ Structure-function requirements of parathyroid hormone for stimulation of 1,25-dihydroxyvitamin D3 production by rat renal proximal tubules. Endocrinology 1993; 133:713-719.
55. Brenza HL, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S, Anazawa H, Suda T, DeLuca HF Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha- hydroxylase gene promoter. Proc Natl Acad Sci U S A 1998; 95:1387-1391.
56. Bikle DD, Rasmussen H The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules. J Clin Invest 1975; 55:292-298.
57. Bikle DD, Murphy EW, Rasmussen H The ionic control of 1,25-dihydroxyvitamin D3 synthesis in isolated chick renal mitochondria. The role of calcium as influenced by inorganic phosphate and hydrogen-ion. J Clin Invest 1975; 55:299-304.
58. Bushinsky DA, Riera GS, Favus MJ, Coe FL Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest 1985; 76:1599-1604.
59. Hulter HN, Halloran BP, Toto RD, Peterson JC Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism. J Clin Invest 1985; 76:695-702.
60. Hughes MR, Brumbaugh PF, Hussler MR, Wergedal JE, Baylink DJ Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science 1975; 190:578-580.
61. Portale AA, Halloran BP, Morris RC, Jr. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 1987; 80:1147-1154.
62. Condamine L, Menaa C, Vrtovsnik F, Vztovsnik F, Friedlander G, Garabedian M Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells. J Clin Invest 1994; 94:1673-1679.
63. Gray RW Control of plasma 1,25-(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: effects of hypophysectomy. Calcif Tissue Int 1981; 33:485-488
64. Yoshida T, Yoshida N, Monkawa T, Hayashi M, Saruta T Dietary phosphorus deprivation induces 25-hydroxyvitamin D(3) 1alpha- hydroxylase gene expression. Endocrinology 2001; 142:1720-1726.
65. Gray RW, Garthwaite TL, Phillips LS Growth hormone and triiodothyronine permit an increase in plasma 1,25(OH)2D concentrations in response to dietary phosphate deprivation in hypophysectomized rats. Calcif Tissue Int 1983; 35:100-106
66. Halloran BP, Spencer EM Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Endocrinology 1988; 123:1225-1229.
67. Saito H, Kusano K, Kinosaki M, Ito H, Hirata M, Segawa H, Miyamoto K, Fukushima N Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 2003; 278:2206-2211
68. White KE, Evan WE, O'Riordan JL, Speer MC, Econs MJ, Lorenz-Depiereux B, Grabowski M, Meitinger T, Storm TM Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000; 26:345-348
69. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001; 98:6500-6505
70. Schuster I, Egger H, Astecker N, Herzig G, Schussler M, Vorisek G Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes. Steroids 2001; 66:451-462.
71. Xie Z, Munson S, Huang N, Schuster I, Portale AA, Miller WL, Bikle DD The mechanism of 1,25-Dihydroxyvitamin D3 auto-regulation in keratinocytes. j bone min Res (Program & abstracts) 2001; 16 suppl 1:S556
72. Kato S, Fujiki R, Kim MS, Kitagawa H Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J Steroid Biochem Mol Biol 2007; 103:372-380
73. Ohyama Y, Okuda K Isolation and characterization of a cytochrome P-450 from rat kidney mitochondria that catalyzes the 24-hydroxylation of 25-hydroxyvitamin D3. J Biol Chem 1991; 266:8690-8695.
74. Akiyoshi-Shibata M, Sakaki T, Ohyama Y, Noshiro M, Okuda K, Yabusaki Y Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase. A study with the mature enzyme expressed in Escherichia coli. Eur J Biochem 1994; 224:335-343.
75. St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, Depovere J, Mathieu C, Christakos S, Demay MB, Glorieux FH Deficient mineralization of intramembranous bone in vitamin D-24- hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000; 141:2658-2666.
76. Hahn CN, Kerry DM, Omdahl JL, May BK Identification of a vitamin D responsive element in the promoter of the rat cytochrome P450(24) gene. Nucleic Acids Res 1994; 22:2410-2416.
77. Chen KS, DeLuca HF Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1995; 1263:1-9.
78. Ohyama Y, Ozono K, Uchida M, Shinki T, Kato S, Suda T, Yamamoto O, Noshiro M, Kato Y Identification of a vitamin D-responsive element in the 5'-flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem 1994; 269:10545-10550.
79. Chen ML, Boltz MA, Armbrecht HJ Effects of 1,25-dihydroxyvitamin D3 and phorbol ester on 25- hydroxyvitamin D3 24-hydroxylase cytochrome P450 messenger ribonucleic acid levels in primary cultures of rat renal cells. Endocrinology 1993; 132:1782-1788.
80. Pike JW, Kerner SA, Jin CH, Allegretto EA, Elgort M Direct activation of the human 25-(OH)2D3 and PMA: Identification of cis elements and transactivators. J Bone Miner Res 1995; 10:S144
81. Garabedian M, Holick MF, Deluca HF, Boyle IT Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci U S A 1972; 69:1673-1676.
82. Shigematsu T, Horiuchi N, Ogura Y, Miyahara T, Suda T Human parathyroid hormone inhibits renal 24-hydroxylase activity of 25- hydroxyvitamin D3 by a mechanism involving adenosine 3',5'- monophosphate in rats. Endocrinology 1986; 118:1583-1589.
83. Armbrecht HJ, Wongsurawat N, Zenser TV, Davis BB Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase. Am J Physiol 1984; 246:E102-107.
84. Armbrecht HJ, Hodam TL, Boltz MA, Partridge NC, Brown AJ, Kumar VB Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25- dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells. Endocrinology 1998; 139:3375-3381.
85. Armbrecht HJ, Wongsurawat VJ, Hodam TL, Wongsurawat N Insulin markedly potentiates the capacity of parathyroid hormone to increase expression of 25-hydroxyvitamin D3-24-hydroxylase in rat osteoblastic cells in the presence of 1,25-dihydroxyvitamin D3. FEBS Lett 1996; 393:77-80.
86. Inoue Y, Segawa H, Kaneko I, Yamanaka S, Kusano K, Kawakami E, Furutani J, Ito M, Kuwahata M, Saito H, Fukushima N, Kato S, Kanayama HO, Miyamoto K Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 2005; 390:325-331
87. Wu S, Grieff M, Brown AJ Regulation of renal vitamin D-24-hydroxylase by phosphate: effects of hypophysectomy, growth hormone and insulin-like growth factor I. Biochem Biophys Res Commun 1997; 233:813-817.
88. Cooke NE, Haddad JG Vitamin D binding protein (Gc-globulin). Endocr Rev 1989; 10:294-307.
89. Bikle DD, Gee E, Halloran B, Haddad JG Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984; 74:1966-1971.
90. Bikle DD, Siiteri PK, Ryzen E, Haddad JG Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 1985; 61:969-975.
91. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986; 63:954-959.
92. Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest 1986; 78:748-752.
93. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 1995; 122:511-513.
94. Cooke NE, David EV Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 1985; 76:2420-2424.
95. Cooke NE, Levan G, Szpirer J The rat vitamin D binding protein (Gc-globulin) gene is syntenic with the rat albumin and alpha-fetoprotein genes on chromosome 14. Cytogenet Cell Genet 1987; 44:98-100
96. Guha C, Osawa M, Werner PA, Galbraith RM, Paddock GV Regulation of human Gc (vitamin D--binding) protein levels: hormonal and cytokine control of gene expression in vitro. Hepatology 1995; 21:1675-1681.
97. Lees A, Haddad JG, Lin S Brevin and DBP comparison of the effects of two serum protein on actin assembly and disassembly. Biochemistry 1984; 23:3038-3047
98. Yamamoto N, Homma S, Haddad JG, Kowalski MA Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells. Immunology 1991; 74:420-424.
99. Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN Effects of vitamin D binding protein-macrophage activating factor (DBP- MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 1995; 16:657-662.
100. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA, Cooke NE Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999; 103:239-251.
101. Haussler MR, Norman AW Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci U S A 1969; 62:155-162.
102. McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 1987; 235:1214-1217.
103. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A 1988; 85:3294-3298.
104. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley BW Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988; 242:1702-1705.
105. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16:391-396.
106. Walters MR Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992; 13:719-764.
107. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 1997; 12:1043-1048.
108. Rachez C, Gamble M, Chang CP, Atkins GB, Lazar MA, Freedman LP The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol 2000; 20:2718-2726.
109. Makowski A, Brzostek S, Cohen RN, Hollenberg AN Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol Endocrinol 2003; 17:273-286
110. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 2000; 5:173-179.
111. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 1996; 3:87-94.
112. Chen S, Cui J, Nakamura K, Ribeiro RC, West BL, Gardner DG Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter. J Biol Chem275:15039-15048.
113. McKenna NJ, Lanz RB, O'Malley BW Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 1999; 20:321-344.
114. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. Faseb J 2000; 14:1455-1463.
115. Xie Z, Chang S, Oda Y, Bikle DD Hairless suppresses vitamin D receptor transactivation in human keratinocytes. Endocrinology 2006; 147:314-323
116. Hsieh JC, Sisk JM, Jurutka PW, Haussler CA, Slater SA, Haussler MR, Thompson CC Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem 2003; 278:38665-38674
117. Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP Development and progression of alopecia in the vitamin D receptor null mouse. J Cell Physiol 2006:340-353
118. Leo C, Chen JD The SRC family of nuclear receptor coactivators. Genes 2000; 245:1-11
119. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, Erdjument-Bromage H, Tempst P, Freedman LP Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999; 398:824-828.
120. Teichert A, Arnold LA, Otieno S, Oda Y, Augustinaite I, Geistlinger TR, Kriwacki RW, Guy RK, Bikle DD Quantification of the vitamin D receptor-coregulator interaction. Biochemistry 2009; 48:1454-1461
121. Oda Y Abstract 809. J Invest Dermatol 2001; 116
122. Hawker NP, Pennypacker SD, Chang SM, Bikle DD Regulation of Human Epidermal Keratinocyte Differentiation by the Vitamin D Receptor and its Coactivators DRIP205, SRC2, and SRC3. J Invest Dermatol 2007; 127:874
123. Schauber J, Oda Y, Buchau AS, Yun QC, Steinmeyer A, Zugel U, Bikle DD, Gallo RL Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J Invest Dermatol 2008; 128:816-824
124. Oda Y, Uchida Y, Moradian S, Crumrine D, Elias PM, Bikle DD Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol 2009; 129:1367-1378
125. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999; 283:1317-1321.
126. Hsieh JC, Jurutka PW, Nakajima S, Galligan MA, Haussler CA, Shimizu Y, Shimizu N, Whitfield GK, Haussler MR Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site. J Biol Chem 1993; 268:15118-15126.
127. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Munoz A Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001; 154:369-387
128. Palmer HG, Anjos-Afonso F, Carmeliet G, Takeda H, Watt FM The Vitamin D Receptor Is a Wnt Effector that Controls Hair Follicle Differentiation and Specifies Tumor Type in Adult Epidermis. PLoS ONE 2008; 3:e1483
129. Kurokawa R, Yu VC, Naar A, Kyakumoto S, Han Z, Silverman S, Rosenfeld MG, Glass CK Differential orientations of the DNA-binding domain and carboxy- terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev 1993; 7:1423-1435.
130. Prufer K, Racz A, Lin GC, Barsony J Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J Biol Chem 2000; 275:41114-41123.
131. Xie Z, Bikle DD Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element. J Biol Chem 1997; 272:6573-6577.
132. Schrader M, Muller KM, Nayeri S, Kahlen JP, Carlberg C Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 1994; 370:382-386.
133. Lemon BD, Freedman LP Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol 1996; 16:1006-1016.
134. MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25- dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cell Biol 1993; 13:5907-5917.
135. Kang S, Li XY, Duell EA, Voorhees JJ The retinoid X receptor agonist 9-cis-retinoic acid and the 24- hydroxylase inhibitor ketoconazole increase activity of 1,25- dihydroxyvitamin D3 in human skin in vivo. J Invest Dermatol 1997; 108:513-518.
136. Gill RK, Christakos S Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses. Proc Natl Acad Sci U S A 1993; 90:2984-2988.
137. Liu SM, Koszewski N, Lupez M, Malluche HH, Olivera A, Russell J Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor. Mol Endocrinol 1996; 10:206-215.
138. Kremer R, Sebag M, Champigny C, Meerovitch K, Hendy GN, White J, Goltzman D Identification and characterization of 1,25-dihydroxyvitamin D3- responsive repressor sequences in the rat parathyroid hormone-related peptide gene. J Biol Chem 1996; 271:16310-16316.
139. Alroy I, Towers TL, Freedman LP Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995; 15:5789-5799.
140. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992; 131:1305-1312.
141. Wistrom CA, Meizel S Evidence suggesting involvement of a unique human sperm steroid receptor/Cl- channel complex in the progesterone-initiated acrosome reaction. Dev Biol 1993; 159:679-690.
142. Koenig H, Fan CC, Goldstone AD, Lu CY, Trout JJ Polyamines mediate androgenic stimulation of calcium fluxes and membrane transport in rat heart myocytes. Circ Res 1989; 64:415-426.
143. Orchinik M, Murray TF, Moore FL A corticosteroid receptor in neuronal membranes. Science 1991; 252:1848-1851.
144. Segal J Thyroid hormone action at the level of the plasma membrane. Thyroid 1990; 1:83-87
145. Caffrey JM, Farach-Carson MC Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J Biol Chem 1989; 264:20265-20274.
146. Baran DT, Sorensen AM, Honeyman TW, Ray R, Holick MF 1 alpha,25-dihydroxyvitamin D3-induced increments in hepatocyte cytosolic calcium and lysophosphatidylinositol: inhibition by pertussis toxin and 1 beta,25-dihydroxyvitamin D3. J Bone Miner Res 1990; 5:517-524.
147. Morelli S, de Boland AR, Boland RL Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblasts treated with 1,25-dihydroxyvitamin D3. Biochem J 1993; 289:675-679.
148. Wali RK, Baum CL, Sitrin MD, Brasitus TA 1,25(OH)2 vitamin D3 stimulates membrane phosphoinositide turnover, activates protein kinase C, and increases cytosolic calcium in rat colonic epithelium. J Clin Invest 1990; 85:1296-1303.
149. Khare S, Bolt MJ, Wali RK, Skarosi SF, Roy HK, Niedziela S, Scaglione-Sewell B, Aquino B, Abraham C, Sitrin MD, Brasitus TA, Bissonnette M 1,25 dihydroxyvitamin D3 stimulates phospholipase C-gamma in rat colonocytes: role of c-Src in PLC-gamma activation. J Clin Invest 1997; 99:1831-1841.
150. Nemere I, Yoshimoto Y, Norman AW Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology 1984; 115:1476-1483.
151. Nemere I, Norman AW Rapid action of 1,25-dihydroxyvitamin D3 on calcium transport in perfused chick duodenum: effect of inhibitors. J Bone Miner Res 1987; 2:99-107.
152. de Boland AR, Norman AW Influx of extracellular calcium mediates 1,25-dihydroxyvitamin D3- dependent transcaltachia (the rapid stimulation of duodenal Ca2+ transport). Endocrinology 1990; 127:2475-2480.
153. de Boland AR, Norman A Evidence for involvement of protein kinase C and cyclic adenosine 3',5' monophosphate-dependent protein kinase in the 1,25-dihydroxy-vitamin D3- mediated rapid stimulation of intestinal calcium transport, (transcaltachia). Endocrinology 1990; 127:39-45.
154. de Boland AR, Nemere I, Norman AW Ca2(+)-channel agonist BAY K8644 mimics 1,25(OH)2-vitamin D3 rapid enhancement of Ca2+ transport in chick perfused duodenum. Biochem Biophys Res Commun 1990; 166:217-222.
155. Nemere I, Dormanen MC, Hammond MW, Okamura WH, Norman AW Identification of a specific binding protein for 1 alpha,25- dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem 1994; 269:23750-23756.
156. Nemere I, Safford SE, Rohe B, DeSouza MM, Farach-Carson MC Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. J Steroid Biochem Mol Biol 2004; 89-90:281-285
157. Pedrozo HA, Schwartz Z, Rimes S, Sylvia VL, Nemere I, Posner GH, Dean DD, Boyan BD Physiological importance of the 1,25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24,25(OH)2D3. J Bone Miner Res 1999; 14:856-867.
158. Khanal RC, Peters TM, Smith NM, Nemere I Membrane receptor-initiated signaling in 1,25(OH)2D3-stimulated calcium uptake in intestinal epithelial cells. J Cell Biochem 2008; 105:1109-1116
159. Norman AW, Okamura WH, Farach-Carson MC, Allewaert K, Branisteanu D, Nemere I, Muralidharan KR, Bouillon R Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6- s-cis analog) stimulates nongenomic but not genomic biological responses. J Biol Chem 1993; 268:13811-13819.
160. Norman AW, Zanello LP, Huhtakangas J, Bula C, Mizwicki M, Olivera C, Zhang X, Okamura WH, Bishop JE, Henry HL A mechanistic conundrum: how can 1,25(OH)2D mediate both genomic responses and rapid responses? Proceedings of the 12th Vitamin D Workshop (in press) 2003;
161. Schachter D, Rosen S Active transport of Ca45 by the small intestine and its dependence on vitamin D. Am J Physiol 1959; 196:357-362
162. Wasserman RH, Kallfelz FA, Comar CL Active transport of calcium by rat duodenum in vivo. Science 1961; 133:883-884
163. Bikle DD 1990 Regulation of intestinal calcium transport by vitamin D [1,25(OH)2]:role of membrane structure. In: Membrane transport and information storage. New York: Wiley-Liss
164. Wasserman RH, Fullmer CS Vitamin D and intestinal calcium transport: facts, speculations and hypotheses. J Nutr 1995; 125:1971S-1979S.
165. Bikle DD, Shoback DM, Munson S 1985 1,25-dihydroxyvitamin D increases the intracellular free calcium concentration of duodenal epithelial cells. In: Vitamin D: Chemial, biochemical and clinical update. New York: Walter de Gruyter
166. Morrissey RL, Zolock DT, Mellick PW, Bikle DD Influence of cycloheximide and 1,25-dihydroxyvitamin D3 on mitochondrial and vesicle mineralization in the intestine. Cell Calcium 1980; 1:69-79
167. Davis WL, Hagler HK, Jones RG, Farmer GR, Cooper OJ, Martin JH, Bridges GE, Goodman DB Cryofixation, ultracryomicrotomy, and X-ray microanalysis of enterocytes from chick duodenum: vitamin-D-induced formation of an apical tubulovesicular system. Anat Rec 1991; 229:227-239.
168. Nemere I, Leathers V, Norman AW 1,25-Dihydroxyvitamin D3-mediated intestinal calcium transport. Biochemical identification of lysosomes containing calcium and calcium- binding protein (calbindin-D28K). J Biol Chem 1986; 261:16106-16114.
169. Max EE, Goodman DB, Rasmussen H Purification and characterization of chick intestine brush border membrane. Effects of 1alpha(OH) vitamin D3 treatment. Biochim Biophys Acta 1978; 511:224-239.
170. Brasitus TA, Dudeja PK, Eby B, Lau K Correction by 1,25(OH)2D3 of the abnormal fluidity and lipid composition of enterocyte brush border membranes in vitamin D-deprived rats. J Biol Chem 1981; 256:3354-3360
171. Matsumoto T, Fontaine O, Rasmussen H Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in chick duodenal mucosal cell. Relationship to its mechanism of action. J Biol Chem 1981; 256:3354-3360.
172. Bikle DD, Whitney J, Munson S The relationship of membrane fluidity to calcium flux in chick intestinal brush border membranes. Endocrinology 1984; 114:260-267.
173. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 1999; 274:22739-22746.
174. Hoenderop JG, van der Kemp AW, Hartog A, van de Graaf SF, van Os CH, Willems PH, Bindels RJ Molecular identification of the apical Ca2+ channel in 1, 25- dihydroxyvitamin D3-responsive epithelia. J Biol Chem 1999; 274:8375-8378.
175. Peng JB, Chen XZ, Berger UV, Vassilev PM, Brown EM, Hediger MA A rat kidney-specific calcium transporter in the distal nephron. J Biol Chem 2000; 275:28186-28194.
176. Muller D, Hoenderop JG, Meij IC, van den Heuvel LP, Knoers NV, den Hollander AI, Eggert P, Garcia-Nieto V, Claverie-Martin F, Bindels RJ Molecular cloning, tissue distribution, and chromosomal mapping of the human epithelial Ca2+ channel (ECAC1). Genomics 2000; 67:48-53.
177. Peng JB, Brown EM, Hediger MA Structural conservation of the genes encoding cat1, cat2, and related cation channels. Genomics 2001; 76:99-109.
178. Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 2003; 144:3885-3894
179. Bianco SD, Peng JB, Takanaga H, Suzuki Y, Crescenzi A, Kos CH, Zhuang L, Freeman MR, Gouveia CH, Wu J, Luo H, Mauro T, Brown EM, Hediger MA Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res 2007; 22:274-285
180. Sampson HW, Matthews JL, Martin JH, Kunin AS An electron microscopic localization of calcium in the small intestine of normal, rachitic, and vitamin-D-treated rats. Calcif Tissue Res 1970; 5:305-316
181. Schaefer HJ Ultrastructure and ion distribution of the intestinal cell during experimental vitamin D deficiency rickets in rats. Virchows Archiv 1973; 359:111-123
182. Chandra S, Fullmer CS, Smith CA, Wasserman RH, Morrison GH Ion microscopic imaging of calcium transport in the intestinal tissue of vitamin D-deficient and vitamin D-replete chickens: a 44Ca stable isotope study. Proc Natl Acad Sci U S A 1990; 87:5715-5719
183. Bikle DD, Zolock DT, Morrissey RL, Herman RH Independence of 1,25-dihydroxyvitamin D3-mediated calcium transport from de novo RNA and protein synthesis. J Biol Chem 1978; 253:484-488.
184. Bikle DD, Morrissey RL, Zolock DT The mechanism of action of vitamin D in the intestine. Am J Clin Nutr 1979; 32:2322-2328.
185. Glenney JR, Jr., Glenney P Comparison of Ca++-regulated events in the intestinal brush border. J Cell Biol 1985; 100:754-763.
186. Bikle DD, Gee E Free, and not total, 1,25-dihydroxyvitamin D regulates 25- hydroxyvitamin D metabolism by keratinocytes. Endocrinology 1989; 124:649-654.
187. Bikle DD, Munson S, Chafouleas J Calmodulin may mediate 1,25-dihydroxyvitamin D-stimulated intestinal calcium transport. FEBS Lett 1984; 174:30-33.
188. Howe CL, Keller TC, 3rd, Mooseker MS, Wasserman RH Analysis of cytoskeletal proteins and Ca2+-dependent regulation of structure in intestinal brush borders from rachitic chicks. Proc Natl Acad Sci U S A 1982; 79:1134-1138.
189. Bikle DD, Munson S The villus gradient of brush border membrane calmodulin and the calcium- independent calmodulin-binding protein parallels that of calcium- accumulating ability. Endocrinology 1986; 118:727-732.
190. Drenckhahn D, Dermietzel R Organization of the actin filament cytoskeleton in the intestinal brush border: a quantitative and qualitative immunoelectron microscope study. J Cell Biol 1988; 107:1037-1048.
191. Wasserman RH, Taylor AN Vitamin D-dependent calcium-binding protein. Response to some physiological and nutritional variables. J Biol Chem 1968; 243:3987-3993.
192. Lee GS, Lee KY, Choi KC, Ryu YH, Paik SG, Oh GT, Jeung EB Phenotype of a calbindin-D9k gene knockout is compensated for by the induction of other calcium transporter genes in a mouse model. J Bone Miner Res 2007; 22:1968-1978
193. Ghijsen WE, De Jong MD, Van Os CH ATP-dependent calcium transport and its correlation with Ca2+ -ATPase activity in basolateral plasma membranes of rat duodenum. Biochim Biophys Acta 1982; 689:327-336.
194. Cai Q, Chandler JS, Wasserman RH, Kumar R, Penniston JT Vitamin D and adaptation to dietary calcium and phosphate deficiencies increase intestinal plasma membrane calcium pump gene expression. Proc Natl Acad Sci U S A 1993; 90:1345-1349.
195. Wasserman RH, Chandler JS, Meyer SA, Smith CA, Brindak ME, Fullmer CS, Penniston JT, Kumar R Intestinal calcium transport and calcium extrusion processes at the basolateral membrane. J Nutr 1992; 122:662-671.
196. Hoenderop JG, Nilius B, Bindels RJ Calcium absorption across epithelia. Physiol Rev 2005; 85:373-422
197. Harrison HE, Harrison HC Intestinal transport of phosphate: Action of vitamin D, calcium, and potassium. Am J Physiol 1961; 201:1007-1012
198. Peterlik M, Wasserman RH Regulation by vitamin D of intestinal phosphate absorption. Horm Metab Res 1980; 12:216-219.
199. Xu H, Bai L, Collins JF, Ghishan FK Molecular cloning, functional characterization, tissue distribution, and chromosomal localization of a human, small intestinal sodium-phosphate (Na+-Pi) transporter (SLC34A2). Genomics 1999; 62:281-284
200. Xu H, Bai L, Collins JF, Ghishan FK Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). Am J Physiol Cell Physiol 2002; 282:C487-493
201. Fuchs R, Peterlik M Vitamin D-induced transepithelial phosphate and calcium transport by chick jejunum. Effect of microfilamentous and microtubular inhibitors. FEBS Lett 1979; 100:357-359.
202. Narbaitz R, Stumpf WE, Sar M, Huang S, DeLuca HF Autoradiographic localization of target cells for 1 alpha, 25- dihydroxyvitamin D3 in bones from fetal rats. Calcif Tissue Int 1983; 35:177-182
203. Boivin G, Mesguich P, Pike JW, Bouillon R, Meunier PJ, Haussler MR, Dubois PM, Morel G Ultrastructural immunocytochemical localization of endogenous 1,25- dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. Bone Miner 1987; 3:125-136.
204. Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 1986; 77:1661-1667.
205. Underwood JL, DeLuca HF Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol 1984; 246:E493-498.
206. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998; 139:4391-4396.
207. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999; 140:4982-4987.
208. Chenu C, Valentin-Opran A, Chavassieux P, Saez S, Meunier PJ, Delmas PD Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short- term cultures. Bone 1990; 11:81-86
209. Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y 1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3. Endocrinology 1990; 126:2088-2094.
210. Scharla SH, Strong DD, Mohan S, Baylink DJ, Linkhart TA 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 1991; 129:3139-3146.
211. Moriwake T, Tanaka H, Kanzaki S, Higuchi J, Seino Y 1,25-Dihydroxyvitamin D3 stimulates the secretion of insulin-like growth factor binding protein 3 (IGFBP-3) by cultured human osteosarcoma cells. Endocrinology 1992; 130:1071-1073.
212. Sato T, Ono T, Tuan RS 1,25-Dihydroxy vitamin D3 stimulation of TGF-beta expression in chick embryonic calvarial bone. Differentiation 1993; 52:139-150.
213. Wang DS, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demura H, Sato K Increase of vascular endothelial growth factor mRNA expression by 1,25- dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 1996; 11:472-479.
214. Lacey DL, Grosso LE, Moser SA, Erdmann J, Tan HL, Pacifici R, Villareal DT IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3. J Clin Invest 1993; 91:1731-1742.
215. Lacey DL, Erdmann JM, Tan HL, Ohara J Murine osteoblast interleukin 4 receptor expression: upregulation by 1,25 dihydroxyvitamin D3. J Cell Biochem 1993; 53:122-134.
216. Nambi P, Wu HL, Lipshutz D, Prabhakar U Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy- vitamin D3. Mol Pharmacol 1995; 47:266-271.
217. Johnson JA, Grande JP, Roche PC, Kumar R Ontogeny of the 1,25-dihydroxyvitamin D3 receptor in fetal rat bone. J Bone Miner Res 1996; 11:56-61.
218. Miller SC, Halloran BP, DeLuca HF, Lee WSS Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats. Calcif Tissue Int 1983; 35:455-460
219. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 1997; 94:9831-9835.
220. Kyeyune-Nyombi E, Lau KH, Baylink DJ, Strong DD 1,25-Dihydroxyvitamin D3 stimulates both alkaline phosphatase gene transcription and mRNA stability in human bone cells. Arch Biochem Biophys 1991; 291:316-325.
221. Irving JT, Wuthier RE Histochemistry and biochemistry of calcification with special reference to the role of lipids. Clin Orthop 1968; 56:237-260.
222. Howell DS, Marquez JF, Pita JC The nature of phospholipids in normal and rachitic costochondral plates. Arthritis Rheum 1965; 8:1039-1046.
223. Dean DD, Boyan BD, Muniz OE, Howell DS, Schwartz Z Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner. Calcif Tissue Int 1996; 59:109-116.
224. Roughley PJ, Dickson IR A comparison of proteoglycan from chick cartilage of different types and a study of the effect of vitamin D on proteoglycan structure. Connect Tissue Res 1986; 14:187-197
225. Plachot JJ, Du Bois MB, Halpern S, Cournot-Witmer G, Garabedian M, Balsan S In vitro action of 1,25-dihydroxycholecalciferol and 24,25- dihydroxycholecalciferol on matrix organization and mineral distribution in rabbit growth plate. Metab Bone Dis Relat Res 1982; 4:135-142
226. Boyan BD, Schwartz Z, Carnes DL, Jr., Ramirez V The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro. Endocrinology 1988; 122:2851-2860.
227. Schwartz Z, Boyan B The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro. Endocrinology 1988; 122:2191-2198.
228. Swain LD, Schwartz Z, Caulfield K, Brooks BP, Boyan BD Nongenomic regulation of chondrocyte membrane fluidity by 1,25-(OH)2D3 and 24,25-(OH)2D3 is dependent on cell maturation. Bone 1993; 14:609-617.
229. Sylvia VL, Schwartz Z, Schuman L, Morgan RT, Mackey S, Gomez R, Boyan BD Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures. J Cell Physiol 1993; 157:271-278.
230. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991; 128:1496-1504.
231. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G Structure of the rat osteocalcin gene and regulation of vitamin D- dependent expression. Proc Natl Acad Sci U S A 1989; 86:1143-1147.
232. Manolagas SC, Burton DW, Deftos LJ 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 1981; 256:7115-7117.
233. Rowe DW, Kream BE Regulation of collagen synthesis in fetal rat calvaria by 1,25- dihydroxyvitamin D3. J Biol Chem 1982; 257:8009-8015.
234. Prince CW, Butler WT 1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res 1987; 7:305-313.
235. Demay MB, Gerardi JM, DeLuca HF, Kronenberg HM DNA sequences in the rat osteocalcin gene that bind the 1,25- dihydroxyvitamin D3 receptor and confer responsiveness to 1,25- dihydroxyvitamin D3. Proc Natl Acad Sci U S A 1990; 87:369-373.
236. Kerner SA, Scott RA, Pike JW Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci U S A 1989; 86:4455-4459.
237. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT Identification of a DNA sequence responsible for binding of the 1,25- dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A 1990; 87:9995-9999.
238. Zhang R, Ducy P, Karsenty G 1,25-dihydroxyvitamin D3 inhibits Osteocalcin expression in mouse through an indirect mechanism. J Biol Chem 1997; 272:110-116.
239. Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization. Endocrinology 1986; 119:2580-2585.
240. Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats. Calcif Tissue Int 1986; 38:79-86.
241. Suda T, Takahashi N, Abe E Role of vitamin D in bone resorption. J Cell Biochem 1992; 49:53-58.
242. Merke J, Klaus G, Hugel U, Waldherr R, Ritz E No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium- deficient chicken despite demonstrable receptors on circulating monocytes. J Clin Invest 1986; 77:312-314.
243. Mee AP, Hoyland JA, Braidman IP, Freemont AJ, Davies M, Mawer EB Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections. Bone 1996; 18:295-299.
244. Rodan GA, Martin TJ Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int 1981; 33:349-351
245. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20:345-357.
246. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998; 95:3597-3602.
247. Takeda S, Yoshizawa T, Nagai Y, Yamato H, Fukumoto S, Sekine K, Kato S, Matsumoto T, Fujita T Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology 1999; 140:1005-1008.
248. Friedman PA, Gesek FA Cellular calcium transport in renal epithelia: measurement, mechanisms, and regulation. Physiol Rev 1995; 75:429-471.
249. Winaver J, Sylk DB, Robertson JS, Chen TC, Puschett JB Micropuncture study of the acute renal tubular transport effects of 25-hydroxyvitamin D3 in the dog. Miner Electrolyte Metab 1980; 4:178-188
250. Tenenhouse HS Cellular and molecular mechanisms of renal phosphate transport. J Bone Miner Res 1997; 12:159-164.
251. Puschett JB, Beck WS, Jr., Jelonek A, Fernandez PC Study of the renal tubular interactions of thyrocalcitonin, cyclic adenosine 3',5'-monophosphate, 25-hydroxycholecalciferol, and calcium ion. J Clin Invest 1974; 53:756-767.
252. Puschett JB, Fernandez PC, Boyle IT, Gray RW, Omdahl JL, DeLuca HF The acute renal tubular effects of 1,25-dihydroxycholecalciferol. Proc Soc Exp Biol Med 1972; 141:379-384.
253. Puschett JB, Moranz J, Kurnick WS Evidence for a direct action of cholecalciferol and 25- hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium. J Clin Invest 1972; 51:373-385.
254. Popovtzer MM, Robinette JB, DeLuca HF, Holick MF The acute effect of 25-hydroxycholecalciferol on renal handling of phosphorus. Evidence for a parathyroid hormone-dependent mechanism. J Clin Invest 1974; 53:913-921.
255. Yamamoto M, Kawanobe Y, Takahashi H, Shimazawa E, Kimura S, Ogata E Vitamin D deficiency and renal calcium transport in the rat. J Clin Invest 1984; 74:507-513.
256. Kumar R, Schaefer J, Grande JP, Roche PC Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P- 450, and calbindin D28k in human kidney. Am J Physiol 1994; 266:F477-485.
257. Borke JL, Minami J, Verma AK, Penniston JT, Kumar R Co-localization of erythrocyte Ca++-Mg++ ATPase and vitamin D-dependent 28-kDa-calcium binding protein. Kidney Int 1988; 34:262-267.
258. Christakos S, Brunette MG, Norman AW Localization of immunoreactive vitamin D-dependent calcium binding protein in chick nephron. Endocrinology 1981; 109:322-324.
259. Roth J, Thorens B, Hunziker W, Norman AW, Orci L Vitamin D--dependent calcium binding protein: immunocytochemical localization in chick kidney. Science 1981; 214:197-200.
260. Bouhtiauy I, Lajeunesse D, Christakos S, Brunette MG Two vitamin D3-dependent calcium binding proteins increase calcium reabsorption by different mechanisms. I. Effect of CaBP 28K. Kidney Int 1994; 45:461-468.
261. Silver J, Russell J, Sherwood LM Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A 1985; 82:4270-4273.
262. Cantley LK, Russell J, Lettieri D, Sherwood LM 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 1985; 117:2114-2119.
263. Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM Sequences in the human parathyroid hormone gene that bind the 1,25- dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 1992; 89:8097-8101.
264. Russell J, Ashok S, Koszewski NJ Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements. J Bone Miner Res 1999; 14:1828-1837.
265. Nishishita T, Okazaki T, Ishikawa T, Igarashi T, Hata K, Ogata E, Fujita T A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D. J Biol Chem 1998; 273:10901-10907.
266. Hawa NS, O'Riordan JL, Farrow SM Functional analysis of vitamin D response elements in the parathyroid hormone gene and a comparison with the osteocalcin gene. Biochem Biophys Res Commun 1996; 228:352-357.
267. Mackey SL, Heymont JL, Kronenberg HM, Demay MB Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol Endocrinol 1996; 10:298-305.
268. Naveh-Many T, Marx R, Keshet E, Pike JW, Silver J Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25- dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 1990; 86:1968-1975.
269. Russell J, Bar A, Sherwood LM, Hurwitz S Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Endocrinology 1993; 132:2639-2644.
270. Dedhar S, Rennie PS, Shago M, Hagesteijn CY, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ, et al. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 1994; 367:480-483.
271. Wheeler DG, Horsford J, Michalak M, White JH, Hendy GN Calreticulin inhibits vitamin D3 signal transduction. Nucleic Acids Res 1995; 23:3268-3274.
272. Sela A, Silver J, Naveh-Many T Chronic hypocalcemia increases PTH mRNA despite high 1,25(OH)2D levels:Roles of calretivulin and the vitamin D receptor. J Bone Miner Res 1996; 11: (abstract)
273. Kadowaki S, Norman AW Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 1985; 34:315-320
274. Lee S, Clark SA, Gill RK, Christakos S 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994; 134:1602-1610
275. Clark SA, Stumpf WE, Sar M, DeLuca HF, Tanaka Y Target cells for 1,25 dihydroxyvitamin D3 in the pancreas. Cell Tissue Res 1980; 209:515-520
276. Morrissey RL, Bucci TJ, Richard B, Empson N, Lufkin EG Calcium-binding protein: its cellular localization in jejunum, kidney and pancreas. Proc Soc Exp Biol Med 1975; 149:56-60
277. Sooy K, Schermerhorn T, Noda M, Surana M, Rhoten WB, Meyer M, Fleischer N, Sharp GW, Christakos S Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines. J Biol Chem 1999; 274:34343-34349
278. Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, Christakos S Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 2001; 142:3649-3655
279. Pittas AG, Lau J, Hu FB, Dawson-Hughes B The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92:2017-2029
280. Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005; 289:G1036-1042
281. Fukumoto S, Yamashita T FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23. Bone 2007; 40:1190-1195
282. Eisman JA, Martin TJ, MacIntyre I, Moseley JM 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet 1979; 2:1335-1336
283. Ingraham BA, Bragdon B, Nohe A Molecular basis of the potential of vitamin D to prevent cancer. Current medical research and opinion 2008; 24:139-149
284. Shah S, Hecht A, Pestell R, Byers SW Trans-repression of beta-catenin activity by nuclear receptors. J Biol Chem 2003; 278:48137-48145
285. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 2006; 21:799-809
286. Dixon KM, Deo SS, Wong G, Slater M, Norman AW, Bishop JE, Posner GH, Ishizuka S, Halliday GM, Reeve VE, Mason RS Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol 2005; 97:137-143
287. De Haes P, Garmyn M, Degreef H, Vantieghem K, Bouillon R, Segaert S 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem 2003; 89:663-673
288. Gupta R, Dixon KM, Deo SS, Holliday CJ, Slater M, Halliday GM, Reeve VE, Mason RS Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol 2007; 127:707-715
289. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985; 1:307-309
290. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol 1993; 137:1302-1317
291. Kearney J, Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Wing A, Kampman E, Willett WC Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996; 143:907-917
292. Garland FC, Garland CF, Gorham ED, Young JF Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990; 19:614-622
293. Hanchette CL, Schwartz GG Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70:2861-2869
294. Boscoe FP, Schymura MJ Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC cancer 2006; 6:264
295. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354:684-696
296. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85:1586-1591
297. Gross C, Stamey T, Hancock S, Feldman D Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). The Journal of urology 1998; 159:2035-2039; discussion 2039-2040
298. Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Redfern CH, Fehrenbacher L, Saleh MN, Waterhouse DM, Carducci MA, Vicario D, Dreicer R, Higano CS, Ahmann FR, Chi KN, Henner WD, Arroyo A, Clow FW Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J Clin Oncol 2007; 25:669-674
299. Lehmann B, Tiebel O, Meurer M Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents-- a preliminary study. Arch Dermatol Res 1999; 291:507-510.
300. Bikle DD, Nemanic MK, Gee E, Elias P 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J Clin Invest 1986; 78:557-566.
301. Bikle DD, Pillai S, Gee E, Hincenbergs M Tumor necrosis factor-alpha regulation of 1,25-dihydroxyvitamin D production by human keratinocytes. Endocrinology 1991; 129:33-38.
302. Bikle DD, Pillai S, Gee E, Hincenbergs M Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 1989; 124:655-660.
303. Pillai S, Bikle DD, Elias PM 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 1988; 263:5390-5395.
304. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 1980; 19:245-254
305. Hennings H, Holbrook KA Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp Cell Res 1983; 143:127-142.
306. Hennings H, Holbrook KA, Yuspa SH Factors influencing calcium-induced terminal differentiation in cultured mouse epidermal cells. J Cell Physiol 1983; 116:265-281.
307. Praeger FC, Stanulis-Praeger BM, Gilchrest BA Use of strontium to separate calcium-dependent pathways for proliferation and differentiation in human keratinocytes. J Cell Physiol 1987; 132:81-89.
308. Pillai S, Bikle DD, Mancianti ML, Cline P, Hincenbergs M Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J Cell Physiol 1990; 143:294-302
309. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 1989; 109:1207-1217
310. Sheu HM, Kitajima Y, Yaoita H Involvement of protein kinase C in translocation of desmoplakins from cytosol to plasma membrane during desmosome formation in human squamous cell carcinoma cells grown in low to normal calcium concentration. Exp Cell Res 1989; 185:176-190.
311. Denning MF, Dlugosz AA, Williams EK, Szallasi Z, Blumberg PM, Yuspa SH Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium. Cell Growth Differ 1995; 6:149-157.
312. Filvaroff E, Calautti E, McCormick F, Dotto GP Specific changes of Ras GTPase-activating protein (GAP) and a GAP- associated p62 protein during calcium-induced keratinocyte differentiation. Mol Cell Biol 1992; 12:5319-5328.
313. Filvaroff E, Calautti E, Reiss M, Dotto GP Functional evidence for an extracellular calcium receptor mechanism triggering tyrosine kinase activation associated with mouse keratinocyte differentiation. J Biol Chem 1994; 269:21735-21740.
314. Rice RH, Green H Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 1979; 18:681-694.
315. Hohl D, Lichti U, Breitkreutz D, Steinert PM, Roop DR Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Dermatol 1991; 96:414-418.
316. Simon M, Green H Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 1984; 36:827-834.
317. Hohl D Cornified cell envelope. Dermatologica 1990; 180:201-211
318. Thacher SM, Rice RH Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell 1985; 40:685-695.
319. Hennings H, Steinert P, Buxman MM Calcium induction of transglutaminase and the formation of epsilon(gamma-glutamyl) lysine cross-links in cultured mouse epidermal cells. Biochem Biophys Res Commun 1981; 102:739-745.
320. Hennings H, Kruszewski FH, Yuspa SH, Tucker RW Intracellular calcium alterations in response to increased external calcium in normal and neoplastic keratinocytes. Carcinogenesis 1989; 10:777-780.
321. Gibson DF, Ratnam AV, Bikle DD Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes. J Invest Dermatol 1996; 106:154-161
322. Su MJ, Bikle DD, Mancianti ML, Pillai S 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium. J Biol Chem 1994; 269:14723-14729.
323. Menon GK, Grayson S, Elias PM Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 1985; 84:508-512
324. Mauro T, Bench G, Sidderas-Haddad E, Feingold K, Elias P, Cullander C Acute barrier perturbation abolishes the Ca2+ and K+ gradients in murine epidermis: quantitative measurement using PIXE. J Invest Dermatol 1998; 111:1198-1201
325. Lee SH, Elias PM, Feingold KR, Mauro T A role for ions in barrier recovery after acute perturbation. J Invest Dermatol 1994; 102:976-979.
326. Menon GK, Price LF, Bommannan B, Elias PM, Feingold KR Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. J Invest Dermatol 1994; 102:789-795.
327. Lee SH, Elias PM, Proksch E, Menon GK, Mao-Quiang M, Feingold KR Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 1992; 89:530-538.
328. Menon GK, Elias PM, Lee SH, Feingold KR Localization of calcium in murine epidermis following disruption and repair of the permeability barrier. Cell Tissue Res 1992; 270:503-512
329. Bikle DD, Ratnam A, Mauro T, Harris J, Pillai S Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest 1996; 97:1085-1093
330. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC Cloning and characterization of an extracellular Ca-2+-sensing receptor from bovine parathyroid. Nature 1993; 366:575-580.
331. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF, Fuller F Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995; 270:12919-12925
332. Tu CL, Chang W, Bikle DD The extracellular calcium-sensing receptor Is Required for calcium- induced differentiation in human keratinocytes. J Biol Chem 2001; 276:41079-41085.
333. Tu C, Chang W, Xie Z, Bikle D Inactivation of the Calcium Sensing Receptor Inhibits E-cadherin-mediated Cell-Cell Adhesion and Calcium-induced Differentiation in Human Epidermal Keratinocytes. J Biol Chem 2008; 283:3519-3528
334. Oda Y, Tu CL, Pillai S, Bikle DD The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation. J Biol Chem 1998; 273:23344-23352
335. Chang W, Tu C, Chen TH, Bikle D, Shoback D The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Science signaling 2008; 1:ra1
336. Jaken S, Yuspa SH Early signals for keratinocyte differentiation: role of Ca2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells. Carcinogenesis 1988; 9:1033-1038.
337. Punnonen K, Denning M, Lee E, Li L, Rhee SG, Yuspa SH Keratinocyte differentiation is associated with changes in the expression and regulation of phospholipase C isoenzymes. J Invest Dermatol 1993; 101:719-726.
338. Xie Z, Bikle DD Phospholipase C-gamma1 is required for calcium-induced keratinocyte differentiation. J Biol Chem 1999; 274:20421-20424
339. Xie Z, Bikle DD The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation. J Biol Chem 2007; 282:8695-8703
340. Xie Z, Singleton PA, Bourguignon LY, Bikle DD Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol Biol Cell 2005; 16:3236-3246
341. Yuspa SH, Ben T, Hennings H, Lichti U Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1982; 42:2344-2349.
342. Dlugosz AA, Yuspa SH Protein kinase C regulates keratinocyte transglutaminase (TG-K) gene expression in cultured primary mouse epidermal keratinocytes induced to terminally differentiate by calcium. J Invest Dermatol 1994; 102:409-414.
343. Lu B, Rothnagel JA, Longley MA, Tsai SY, Roop DR Differentiation-specific expression of human keratin 1 is mediated by a composite AP-1/steroid hormone element. J Biol Chem 1994; 269:7443-7449.
344. Ng DC, Shafaee S, Lee D, Bikle DD Requirement of an AP-1 site in the calcium response region of the involucrin promoter. J Biol Chem 2000; 275:24080-24088.
345. Bikle DD, Ng D, Oda Y, Hanley K, Feingold K, Xie Z The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3. J Invest Dermatol 2002; 119:1109-1113
346. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology 1983; 113:1950-1957.
347. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979; 206:1188-1190.
348. Smith EL, Walworth NC, Holick MF Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86:709-714.
349. Pillai S, Bikle DD Role of intracellular-free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D3. J Cell Physiol 1991; 146:94-100.
350. McLane JA, Katz M, Abdelkader N Effect of 1,25-dihydroxyvitamin D3 on human keratinocytes grown under different culture conditions. In Vitro Cell Dev Biol 1990; 26:379-387.
351. McLaughlin JA, Cantley LC, Holick MF 1,25(OH)2D3 increased calcium and phosphatidylinositol metabolism in differentiating cultured human keratinocytes. J Nutr Biochem 1990; 1:81-87
352. Ratnam AV, Bikle DD, Cho JK 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes. J Cell Physiol 1999; 178:188-196
353. Pillai S, Bikle DD, Su MJ, Ratnam A, Abe J 1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels. J Clin Invest 1995; 96:602-609.
354. Xie Z, Bikle DD Inhibition of 1,25-Dihydroxyvitamin-D-Induced Keratinocyte Differentiation by Blocking the Expression of Phospholipase C-gamma1. J Invest Dermatol 2001; 117:1250-1254.
355. van Etten E, Mathieu C Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005; 97:93-101
356. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. The Journal of pharmacology and experimental therapeutics 2008; 324:23-33
357. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945-1953
358. Sakaguchi S, Yamaguchi T, Nomura T, Ono M Regulatory T cells and immune tolerance. Cell 2008; 133:775-787
359. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nature immunology 2007; 8:285-293
360. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179:1634-1647
361. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29:726-776
362. Adorini L, Penna G Control of autoimmune diseases by the vitamin D endocrine system. Nature clinical practice 2008; 4:404-412
363. Adamopoulos IE, Bowman EP Immune regulation of bone loss by Th17 cells. Arthritis research & therapy 2008; 10:225
364. Mathieu C, Van Etten E, Gysemans C, Decallonne B, Kato S, Laureys J, Depovere J, Valckx D, Verstuyf A, Bouillon R In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res 2001; 16:2057-2065
365. O'Kelly J, Hisatake J, Hisatake Y, Bishop J, Norman A, Koeffler HP Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest 2002; 109:1091-1099
366. Josien R, Li HL, Ingulli E, Sarma S, Wong BR, Vologodskaia M, Steinman RM, Choi Y TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. The Journal of experimental medicine 2000; 191:495-502
367. Baroni E, Biffi M, Benigni F, Monno A, Carlucci D, Carmeliet G, Bouillon R, D'Ambrosio D VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3. J Leukoc Biol 2007; 81:250-262
368. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17:2386-2392
369. Gysemans C, van Etten E, Overbergh L, Giulietti A, Eelen G, Waer M, Verstuyf A, Bouillon R, Mathieu C Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 2008; 57:269-275
370. Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol 2004; 34:1068-1076
371. Wittke A, Weaver V, Mahon BD, August A, Cantorna MT Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J Immunol 2004; 173:3432-3436
372. Wittke A, Chang A, Froicu M, Harandi OF, Weaver V, August A, Paulson RF, Cantorna MT Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. Arch Biochem Biophys 2007; 460:306-313
373. Adorini L Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cellular immunology 2005; 233:115-124
374. Ehrchen J, Helming L, Varga G, Pasche B, Loser K, Gunzer M, Sunderkotter C, Sorg C, Roth J, Lengeling A Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. Faseb J 2007; 21:3208-3218
375. Rajapakse R, Mousli M, Pfaff AW, Uring-Lambert B, Marcellin L, Bronner C, Jeanblanc M, Villard O, Letscher-Bru V, Klein JP, Candolfi E 1,25-Dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis. J Steroid Biochem Mol Biol 2005; 96:179-185
376. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature immunology 2002; 3:673-680
377. Liu PT, Krutzik SR, Modlin RL Therapeutic implications of the TLR and VDR partnership. Trends in molecular medicine 2007; 13:117-124
378. Schauber J, Gallo RL The vitamin D pathway: a new target for control of the skin's immune response? Exp Dermatol 2008; 17:633-639
379. Gombart AF, Borregaard N, Koeffler HP Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Faseb J 2005; 19:1067-1077
380. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909-2912
381. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zugel U, Bikle DD, Modlin RL, Gallo RL Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007; 117:803-811
382. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-1773
383. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-1160
384. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, Leung DY Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006; 24:341-348
385. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005; 50:432-437
386. Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, Stanford J Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57:159-163
387. Liu PT, Stenger S, Tang DH, Modlin RL Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179:2060-2063
388. Sly LM, Lopez M, Nauseef WM, Reiner NE 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 2001; 276:35482-35493
389. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285:732-736
390. Schauber J, Oda Y, Buchau AS, Yun QC, Steinmeyer A, Zugel U, Bikle DD, Gallo RL Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D(3). J Invest Dermatol 2008; 128:816-824
391. Norman AW, Roth J, Orci L The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 1982; 3:331-366.
392. Weishaar RE, Kim SN, Saunders DE, Simpson RU Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol 1990; 258:E134-142.
393. Walters MR, Ilenchuk TT, Claycomb WC 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells. J Biol Chem 1987; 262:2536-2541.
394. Selles J, Boland R Rapid stimulation of calcium uptake and protein phosphorylation in isolated cardiac muscle by 1,25-dihydroxyvitamin D3. Mol Cell Endocrinol 1991; 77:67-73.
395. Wu J, Garami M, Cao L, Li Q, Gardner DG 1,25(OH)2D3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes. Am J Physiol 1995; 268:E1108-1113.
396. Boland R Role of vitamin D in skeletal muscle function. Endocr Rev 1986; 7:434-448.
397. Gelbard HA, Stern PH, U'Prichard DC 1 alpha, 25-Dihydroxyvitamin D3 nuclear receptors in pituitary. Science 1980; 209:1247-1249.
398. Haug E, Gautvik KM Demonstration and characterization of a 1 alpha,25-(OH)2D3 receptor- like macromolecule in cultured rat pituitary cells. J Steroid Biochem 1985; 23:625-635.
399. Tornquist K Pretreatment with 1,25-dihydroxycholecalciferol enhances thyrotropin- releasing hormone- and inositol 1,4,5-trisphosphate-induced release of sequestered Ca2+ in permeabilized GH4C1 pituitary cells. Endocrinology 1992; 131:1677-1681.
400. Tornquist K, Lamberg-Allardt C The effect of 1,25-dihydroxy-cholecalciferol on the TRH induced TSH release in rats. Acta Endocrinol (Copenh) 1987; 114:55-59.
401. Narbaitz R, Sar M, Stumpf WE, Huang S, DeLuca HF 1,25-Dihydroxyvitamin D3 target cells in rat mammary gland. Horm Res 1981; 15:263-269
402. Eisman JA, Suva LJ, Martin TJ Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers. Cancer Res 1986; 46:5406-5408.
403. Eisman JA, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang GY Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells. J Cell Physiol 1989; 138:611-616.
404. Colston KW, Berger U, Coombes RC Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1989; 1:188-191.
405. Duncan WE, Whitehead D, Wray HL A 1,25-dihydroxyvitamin D3 receptor-like protein in mammalian and avian liver nuclei. Endocrinology 1988; 122:2584-2589.
406. Rixon RH, MacManus JP, Whitfield JF The control of liver regeneration by calcitonin, parathyroid hormone and 1 alpha,25-dihydroxycholecalciferol. Mol Cell Endocrinol 1979; 15:79-89.
407. Nguyen TM, Guillozo H, Marin L, Dufour ME, Tordet C, Pike JW, Garabedian M 1,25-dihydroxyvitamin D3 receptors in rat lung during the perinatal period: regulation and immunohistochemical localization. Endocrinology 1990; 127:1755-1762.
408. Giovannucci E, Liu Y, Hollis BW, Rimm EB 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of internal medicine 2008; 168:1174-1180
409. Marin L, Dufour ME, Tordet C, Nguyen M 1,25(OH)2D3 stimulates phospholipid biosynthesis and surfactant release in fetal rat lung explants. Biol Neonate 1990; 57:257-260
410. Gaultier C, Harf A, Balmain N, Cuisinier-Gleizes P, Mathieu H Lung mechanics in rachitic rats. Am Rev Respir Dis 1984; 130:1108-1110.